Department of Justice January 2020 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V
Document Number: 2020-01957
Type: Rule
Date: 2020-01-31
Agency: Drug Enforcement Administration, Department of Justice
On October 11, 2019, the U.S. Food and Drug Administration approved a new drug application for Reyvow (lasmiditan) tablets for oral use. Lasmiditan is chemically known as [2,4,6-trifluoro-N-(6-(1- methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]. Thereafter, the Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place lasmiditan in schedule V of the Controlled Substances Act (CSA). In accordance with the CSA, as revised by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing lasmiditan, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule V of the CSA.
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Odva, Inc.
Document Number: 2020-01820
Type: Notice
Date: 2020-01-31
Agency: Antitrust Division, Department of Justice
Notice Pursuant to the National Cooperative Research and Production Act of 1993-ODPI, Inc.
Document Number: 2020-01751
Type: Notice
Date: 2020-01-31
Agency: Antitrust Division, Department of Justice
Notice Pursuant to the National Cooperative Research and Production Act of 1993-CHEDE-8
Document Number: 2020-01752
Type: Notice
Date: 2020-01-30
Agency: Antitrust Division, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I of the Controlled Substances Act
Document Number: 2020-01683
Type: Rule
Date: 2020-01-30
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of cyclopentyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide), para- chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin- 4-yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)- N-(1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylpentanamide) including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers. The schedule I status of cyclopentyl fentanyl, isobutyryl fentanyl, para- chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl currently is in effect until February 1, 2020. This temporary order will extend the temporary scheduling of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para- methoxybutyryl fentanyl, and valeryl fentanyl for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first.
Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl Into Schedule I
Document Number: 2020-01681
Type: Proposed Rule
Date: 2020-01-30
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylisobutyramide), para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1- phenethylpiperidin-4-yl)-N-phenylpentanamide), including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers and salts is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para- methoxybutyryl fentanyl, and valeryl fentanyl.
Agency Information Collection Activities; Proposed eCollection eComments Requested; COPS Progress Report
Document Number: 2020-01535
Type: Notice
Date: 2020-01-29
Agency: Department of Justice
The Department of Justice (DOJ) Office of Community Oriented Policing Services (COPS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Meeting of the Coordinating Council on Juvenile Justice and Delinquency Prevention
Document Number: 2020-01428
Type: Notice
Date: 2020-01-28
Agency: Department of Justice, Office of Justice Programs
The Coordinating Council on Juvenile Justice and Delinquency Prevention announces its next meeting.
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection
Document Number: 2020-01216
Type: Notice
Date: 2020-01-27
Agency: Federal Bureau of Investigation, Department of Justice
The Department of Justice, Federal Bureau of Investigation, Training Division is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: Annual Survey of Jails
Document Number: 2020-01215
Type: Notice
Date: 2020-01-27
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection; Initial Suitability Request-ATF 3252.4
Document Number: 2020-01214
Type: Notice
Date: 2020-01-27
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension With Change of a Currently Approved Collection; Request for ATF Background Investigation Information-ATF Form 8620.65
Document Number: 2020-01213
Type: Notice
Date: 2020-01-27
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Currently Approved Collection Application for Alternate Means of Identification of Firearm(s) (Marking Variance)-ATF Form 3311.4
Document Number: 2020-01212
Type: Notice
Date: 2020-01-27
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Additions to Listing of Exempt Chemical Mixtures
Document Number: 2020-00667
Type: Rule
Date: 2020-01-27
Agency: Drug Enforcement Administration, Department of Justice
Under this direct final rule, the Drug Enforcement Administration (DEA) is updating the Table of Exempt Chemical Mixtures to include the listing of 15 additional preparations. This action is in response to DEA's review of new applications for exemption. Having reviewed applications and relevant information, DEA finds that these preparations meet the applicable exemption criteria. Therefore, these products are exempted from the application of certain provisions of the Controlled Substances Act.
Sunshine Act Meeting
Document Number: 2020-01281
Type: Notice
Date: 2020-01-24
Agency: Foreign Claims Settlement Commission, Department of Justice
Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV
Document Number: 2020-00669
Type: Rule
Date: 2020-01-24
Agency: Drug Enforcement Administration, Department of Justice
This final rule adopts without change an interim final rule with request for comments published in the Federal Register on June 17, 2019. That interim final rule placed the substance brexanolone (3[alpha]-hydroxy-5[alpha]-pregnan-20-one), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule IV of the Controlled Substances Act. With the issuance of this final rule, the Drug Enforcement Administration maintains brexanolone in schedule IV of the Controlled Substances Act.
Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I
Document Number: 2020-00665
Type: Rule
Date: 2020-01-24
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places methyl 2-(1-(5- fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoat e [5F-ADB; 5F-MDMB-PINACA]; methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate [5F-AMB]; N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide [5F-APINACA, 5F-AKB48]; N-(1- amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-ind azole-3- carboxamide [ADB-FUBINACA]; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA, MMB-CHMINACA]; and methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate [MDMB-FUBINACA], including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle 5F- ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA, and MDMB-FUBINACA.
Schedules of Controlled Substances: Removal of 6β-Naltrexol From Control
Document Number: 2020-00664
Type: Rule
Date: 2020-01-24
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Acting Administrator of the Drug Enforcement Administration removes (5[alpha],6[beta])-17- (cyclopropylmethyl)-4,5-epoxymorphinan-3,6,14-triol (6[beta]-naltrexol) and its salts from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, 6[beta]-naltrexol was a schedule II controlled substance because it can be derived from opium alkaloids. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle 6[beta]-naltrexol.
Privacy Act of 1974; Systems of Records
Document Number: 2020-00786
Type: Notice
Date: 2020-01-21
Agency: Department of Justice
Pursuant to the Privacy Act of 1974, and Office of Management and Budget (OMB) Circular No. A-108, notice is hereby given that the Office of Community Oriented Policing Services (COPS Office), a component within the United States Department of Justice (DOJ or Department), proposes to develop a new system of records notice titled COPS Management System: NexGen (CMS:NxG), JUSTICE/COPS-003. The COPS Office proposes to establish this system of records to consolidate its various business databases, applications, and web applications under one umbrella to support the grant-making and grant management processes from the pre-award phase, including posting solicitations and administering applications for COPS Office funding, to the post-award phase, including budget modifications and award monitoring activities. Previously, grant-making and grant management was handled by a legacy system covered under the DOJ-003 Correspondence Management Systems (CMS) SORN. Because certain aspects of NexGen are more consistent with a separate system of records, COPS is issuing a new SORN to make that clear.
Meeting of the Federal Advisory Committee on Juvenile Justice
Document Number: 2020-00692
Type: Notice
Date: 2020-01-17
Agency: Department of Justice, Office of Justice Programs
The Office of Juvenile Justice and Delinquency Prevention is updating its meeting notice, published on December 20, 2019, because it has re-scheduled the meeting of the Federal Advisory Committee on Juvenile Justice (FACJJ), that had been scheduled for January 7, 2020, but was postponed due to inclement weather causing early closure of Washington, DC-area federal offices on the scheduled meeting date.
Importer of Controlled Substances Application: S&B Pharma, Inc.
Document Number: 2020-00661
Type: Notice
Date: 2020-01-17
Agency: Drug Enforcement Administration, Department of Justice
Equal Participation of Faith-Based Organizations in Department of Justice's Programs and Activities: Implementation of Executive Order 13831
Document Number: 2019-27777
Type: Proposed Rule
Date: 2020-01-17
Agency: Department of Justice
The rule proposes to amend Department of Justice (``Department'') regulations on equal treatment for faith-based and other neighborhood organizations and to implement Executive Order 13831 (Establishment of a White House Faith and Opportunity Initiative). Among other changes, this rule proposes changes to provide clarity about the rights and obligations of faith-based organizations participating in Department programs, clarify the Department's guidance documents for financial assistance in regard to faith-based organizations, and eliminate certain requirements for faith-based organizations that no longer reflect executive branch guidance. This proposed rulemaking is intended to ensure that the Department's social service programs are implemented in a manner consistent with the requirements of Federal law, including the First Amendment to the Constitution and the Religious Freedom Restoration Act.
Agency Information Collection Activities; Proposed eCollection eComments Requested
Document Number: 2020-00527
Type: Notice
Date: 2020-01-15
Agency: Department of Justice
The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Currently Approved Collection
Document Number: 2020-00526
Type: Notice
Date: 2020-01-15
Agency: Department of Justice, Office of Justice Programs
The Department of Justice, Office of Justice Programs, National Institute of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; COPS Application Package
Document Number: 2020-00525
Type: Notice
Date: 2020-01-15
Agency: Department of Justice
The Department of Justice (DOJ) Office of Community Oriented Policing Services (COPS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection; Credit Card Payment Form (1-786)
Document Number: 2020-00524
Type: Notice
Date: 2020-01-15
Agency: Federal Bureau of Investigation, Department of Justice
Department of Justice (DOJ), Federal Bureau of Investigation, Criminal Justice Information Services Division will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection Report of Theft or Loss of Controlled Substance DEA Form 106
Document Number: 2020-00523
Type: Notice
Date: 2020-01-15
Agency: Department of Justice
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.